| Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease S Spoerl, NR Mathew, M Bscheider, A Schmitt-Graeff, S Chen, T Mueller, ... Blood, The Journal of the American Society of Hematology 123 (24), 3832-3842, 2014 | 433 | 2014 |
| Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells NR Mathew, F Baumgartner, L Braun, D O'Sullivan, S Thomas, ... Nature medicine 24 (3), 282-291, 2018 | 267 | 2018 |
| Single-cell BCR and transcriptome analysis after influenza infection reveals spatiotemporal dynamics of antigen-specific B cells NR Mathew, JK Jayanthan, IV Smirnov, JL Robinson, H Axelsson, ... Cell reports 35 (12), 2021 | 80 | 2021 |
| BRAF inhibitor–associated ERK activation drives development of chronic lymphocytic leukemia N Yaktapour, F Meiss, J Mastroianni, T Zenz, H Andrlova, NR Mathew, ... The Journal of clinical investigation 124 (11), 5074-5084, 2014 | 70 | 2014 |
| Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia NR Mathew, JM Vinnakota, P Apostolova, D Erny, S Hamarsheh, ... The Journal of clinical investigation 130 (3), 1315-1329, 2020 | 51 | 2020 |
| Recombinant influenza vaccines: saviors to overcome immunodominance NR Mathew, D Angeletti Frontiers in immunology 10, 2997, 2020 | 24 | 2020 |
| Longitudinal single-cell analysis of SARS-CoV-2–reactive B cells uncovers persistence of early-formed, antigen-specific clones L Scharf, H Axelsson, A Emmanouilidi, NR Mathew, DJ Sheward, S Leach, ... JCI insight 8 (1), 2023 | 10 | 2023 |
| Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells NR Mathew, F Baumgartner, L Braun, D O'Sullivan, S Thomas, ... Nature Medicine 24 (4), 526-526, 2018 | 8 | 2018 |
| Single-cell BCR and transcriptome analysis after influenza infection reveals spatiotemporal dynamics of antigen-specific B cells (vol 35, 109286, 2021) NR Mathew, JK Jayanthan, IV Smirnov, JL Robinson, H Axelsson, ... CELL REPORTS 41 (9), 2022 | 5 | 2022 |
| Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in leukemia cells NR Mathew, F Baumgartner, M Waterhouse, TA Müller, A Schmitt-Gräff, ... Biology of Blood and Marrow Transplantation 22 (3), S90, 2016 | 3 | 2016 |
| Single cell BCR and transcriptome analysis after respiratory virus infection reveals spatiotemporal dynamics of antigen-specific B cell responses NR Mathew, JK Jayanthan, I Smirnov, JL Robinson, H Axelsson, ... bioRxiv, 2020.08. 24.264069, 2020 | 1 | 2020 |
| Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (vol 24, pg 282, 2018) NR Mathew, F Baumgartner, L Braun, D O'Sullivan, S Thomas, ... NATURE MEDICINE 24 (4), 526-526, 2018 | 1 | 2018 |
| Nasal tissue-resident memory CD4+ T cells persist after influenza A virus infection and provide heterosubtypic protection NR Mathew, R Gailleton, L Scharf, K Schön, A Strömberg, N Lycke, ... bioRxiv, 2024.07. 06.602325, 2024 | | 2024 |
| Inhibition of oncogenic FLT3 to enhance anti-leukemia responses via IL-15 N Mathew, J Finke, J Duyster, R Zeiser ONCOLOGY RESEARCH AND TREATMENT 41, 41-41, 2018 | | 2018 |
| Targeting Tyrosine Kinases for the Treatment of FLT3-ITD Mutant Acute Myeloid Leukemia and Acute Graft-versus-host Disease NR Mathew Albert-Ludwigs-Universität Freiburg im Breisgau, 2017 | | 2017 |
| JAK 1/2 blockade reduces clinical graft-versus-host disease S Spoerl, N Mathew, M Verbeek, K Maas-Bauer, J Finke, C Peschel, ... ONCOLOGY RESEARCH AND TREATMENT 37, 228-228, 2014 | | 2014 |
| JAK1/2 Inhibition Suppresses T Cell Proliferation and Inflammatory Cytokine Production In An Allogeneic Setting and Ameliorates Graft-Versus-Host Disease (GvHD) In a Murine … S Spoerl, S Chen, M Bscheider, N Mathew, M Schmickl, T Mueller, ... Blood 122 (21), 3253, 2013 | | 2013 |
